The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Antimicrobial Resistance in Haemophilus influenzae
Open accessAbstract
SUMMARY: Haemophilus influenzae is a major community-acquired pathogen causing significant morbidity and mortality worldwide. Meningitis and bacteremia due to type b strains occur in areas where the protein-conjugated type b vaccine is not in use, whereas nontypeable strains are major causes of otitis media, sinusitis, acute exacerbations of chronic bronchitis, and pneumonia. Antibiotic resistance in this organism is more diverse and widespread than is commonly appreciated. Intrinsic efflux resistance mechanisms limit the activity of the macrolides, azalides, and ketolides. β-Lactamase production is highly prevalent worldwide and is associated with resistance to ampicillin and amoxicillin. Strains with alterations in penicillin binding proteins, particularly PBP3 (β-lactamase negative ampicillin resistant and β-lactamase positive amoxicillin-clavulanate resistant), are increasing in prevalence, particularly in Japan, with increasing resistance to ampicillin, amoxicillin, amoxicillin-clavulanate, and many cephalosporins, limiting the efficacy of expanded-spectrum cephalosporins against meningitis and of many oral cephalosporins against other diseases. Most strains remain susceptible to the carbapenems, which are not affected by penicillin binding protein changes, and the quinolones. The activity of many oral agents is limited by pharmacokinetics achieved with administration by this route, and the susceptibility of isolates based on pharmacokinetic and pharmacodynamic parameters is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 2×
“PK describes the body’s absorption, distribution, metabolism, and elimination of drugs, while PD examines the in vivo relationship between the target pathogen and the antimicrobial agent over time, taking into account the effects of variations in drug concentrations on killing and organism growth dynamics (3, 5, 29).”
BackgroundBradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308 · cited 3×
“A fluoroquinolone, either gatifloxacin or moxifloxacin, can be added to the list of recommended alternative agents for adult patients only (146).”
BackgroundInfluentialNiederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Wang, J. C. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003313 · Cited by 1,540
Peltola, H. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.302-317.2000 · Cited by 1,364
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
Ambrose, P. G., Bhavnani, S. M., Rubino, C. M., Louie, A., Gumbo, T., Forrest, A., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510079 · Cited by 697
The Diagnosis and Management of Acute Otitis Media
(2021) · Pediatric Clinical Practice Guidelines & Policies, 21st Ed · doi:10.1542/9781610025034-part01-the_diagnosis · Cited by 692
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
Partnership, S. A. A. H. (2004) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2003.12.003 · Cited by 535
Jacobs, M. R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg321 · Cited by 467
Self-citationChanges in Frequency and Pathogens Causing Acute Otitis Media in 1995–2003
Casey, J. R., & Pichichero, M. E. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000136871.51792.19 · Cited by 417
Turnidge, J., Kahlmeter, G., & Kronvall, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01377.x · Cited by 397
Detection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307
Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Self-citationTait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Self-citationInhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Chaibi, E. B., Sirot, D., Paul, G., & Labia, R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.447 · Cited by 256
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
MacGowan, A. P., & Wise, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.17 · Cited by 187
Dabernat, H., Delmas, C., Seguy, M., Pelissier, R., Faucon, G., Bennamani, S., & Pasquier, C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2208-2218.2002 · Cited by 185
X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme
Pares, S., Mouz, N., Pétillot, Y., Hakenbeck, R., & Dideberg, O. (1996) · Nature Structural Biology · doi:10.1038/nsb0396-284 · Cited by 183
Plasmid-linked ampicillin resistance in haempohilus influenza type b
Elwell, L. P., De Graaff, J., Seibert, D., & Falkow, S. (1975) · Infection and Immunity · doi:10.1128/iai.12.2.404-410.1975 · Cited by 165
Editorial: The people behind the publication
Benninger, M. S. (2004) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2003.12.001 · Cited by 161
Perić, M., Bozdoğan, B., Jacobs, M. R., & Appelbaum, P. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1017-1022.2003 · Cited by 156
Self-citationMacrolide Resistance in Bacteremic Pneumococcal Disease: Implications for Patient Management
McGeer, A., Green, A. K., Low, D. E., & Toronto Invasive Bacterial Diseases Network (2006) · Clinical Infectious Diseases · doi:10.1086/505871 · Cited by 153
Diversity of Ampicillin-Resistance Genes in Haemophilus influenzae in Japan and the United States
Hasegawa, K., Yamamoto, K., Chiba, N., Kobayashi, R., Nagai, K., Jacobs, M. R., Appelbaum, P. C., Sunakawa, K., & Ubukata, K. (2003) · Microbial Drug Resistance · doi:10.1089/107662903764736337 · Cited by 152
Self-citationAdrian, P. V., & Klugman, K. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2406 · Cited by 149
The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump
Sánchez, L., Pan, W., Viñas, M., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6855-6857.1997 · Cited by 142
Hasegawa, K., Chiba, N., Kobayashi, R., Murayama, S. Y., Iwata, S., Sunakawa, K., & Ubukata, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1509-1514.2004 · Cited by 134
Canadian Guidelines for the Management of Acute Exacerbations of Chronic Bronchitis
Balter, M. S., Forge, J. L., Low, D. E., Mandell, L. A., Grossman, R. F., & the Chronic Bronchitis Working Group (2003) · Canadian Respiratory Journal · doi:10.1155/2003/486285 · Cited by 133
Weiss, D. S., Pogliano, K., Carson, M., Guzman, L., Fraipont, C., Nguyen‐Distèche, M., Losick, R. M., & Beckwith, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.5041869.x · Cited by 128
Mohd-Zain, Z., Turner, S. L., Cerdeño-Tárraga, A. M., Lilley, A. K., Inzana, T. J., Duncan, A. J., Harding, R. M., Hood, D. W., Peto, T., & Crook, D. W. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.23.8114-8122.2004 · Cited by 124
Andes, D. R., Anon, J. B., Jacobs, M. R., & Craig, W. A. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.009 · Cited by 106
Self-citationKaczmarek, F. S., Gootz, T. D., Dib-Hajj, F. B., Shang, W., Hallowell, S., & Cronan, M. T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1630-1639.2004 · Cited by 106
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae
Burns, J. L., Mendelman, P. M., Levy, J., Stull, T. L., & Smith, A. L. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.46 · Cited by 104
Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children
Jacobs, M. R. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200308001-00002 · Cited by 101
Self-citationUpdate on Mechanisms and Prevalence of Antimicrobial Resistance in Haemophilus influenzae
Jorgensen, J. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.5.1119 · Cited by 98
Clairoux, N., Picard, M., Brochu, A., Rousseau, N., Gourde, P., Beauchamp, D., Parr, T. R., Bergeron, M. G., & Malouin, F. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.7.1504 · Cited by 97
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa
von Gottberg, A., de Gouveia, L., Madhi, S. A., du Plessis, M., Quan, V., Soma, K., Huebner, R., Flannery, B., Schuchat, A., & Klugman, K. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.06.030361 · Cited by 94
Heilmann, K. P., Rice, C., Miller, A. L., Miller, N. J., Beekmann, S. E., Pfaller, M. A., Richter, S. S., & Doern, G. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2561-2564.2005 · Cited by 86
Pikis, A., Donkersloot, J. A., Rodriguez, W. J., & Keith, J. M. (1998) · The Journal of Infectious Diseases · doi:10.1086/515371 · Cited by 83
Bacterial eradication in the treatment of otitis media
Dagan, R., & Leibovitz, E. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00394-8 · Cited by 82
Hasegawa, K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl142 · Cited by 80
Bradley, J. S. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00035 · Cited by 70
BRUNTON, J. L., Clare, D., & Meier, M. A. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.5.713 · Cited by 65
Subtyping of Haemophilus influenzae Strains by Pulsed-Field Gel Electrophoresis
Saito, M., Umeda, A., & Yoshida, S. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2142-2147.1999 · Cited by 64
Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae
Mendelman, P. M., Chaffin, D. O., & Kalaitzoglou, G. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.525 · Cited by 62
Liu, P., Rand, K. H., Obermann, B., & Derendorf, H. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.012 · Cited by 59
Karlowsky, J. A., Critchley, I. A., Blosser-Middleton, R. S., Karginova, E. A., Jones, M. E., Thornsberry, C., & Sahm, D. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.1063-1066.2002 · Cited by 55
Clark, C., Bozdoğan, B., Perić, M., Dewasse, B. E., Jacobs, M. R., & Appelbaum, P. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2956-2962.2002 · Cited by 49
Self-citationGenetic determinant of the ROB-1 beta-lactamase in bovine and porcine Pasteurella strains
Livrelli, V., Darfeuille, A., Rich, C., Joly, B., & Martel, J. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1282 · Cited by 46
Davies, T. A., Kelly, L. M., Hoellman, D. B., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.633-639.2000 · Cited by 44
Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae
Bogdanovich, T., Bozdoğan, B., & Appelbaum, P. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.893-898.2006 · Cited by 43
Self-citationMechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli
Wu, P., Shannon, K. P., & Phillips, I. R. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.6.927 · Cited by 41
Smith‐Vaughan, H., Sriprakash, K. S., Leach, A. J., Mathews, J. D., & Kemp, D. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.7.3403-3409.1998 · Cited by 38
Ambrose, P. G., Anon, J. B., Owen, J. S., Wart, S. V., McPhee, M. E., Bhavnani, S. M., PIEDMONTE, M. R., & Jones, R. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420739 · Cited by 38
Nature of the Bactericidal Action of Sulfonamides and Trimethoprim, Alone and in Combination
Then, R. L., & Angehrn, P. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s498 · Cited by 38
Dimopoulou, I. D., Russell, J. E., Mohd-Zain, Z., Herbert, R., & Crook, D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1602-1603.2002 · Cited by 37
Eucast Technical Note on daptomycin
* (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01455.x · Cited by 31
Sethi, S., & Murphy, T. F. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.07.006 · Cited by 30
Plasmid-mediated Tet M in Haemophilus ducreyi
Roberts, M. C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1611 · Cited by 30
Watanabe, H., Hoshino, K., Sugita, R., Asoh, N., Watanabe, K., Oishi, K., & Nagatake, T. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.362-365.2004 · Cited by 28
Trimethoprim resistance in Haemophilus influenzae is due to altered dihydrofolate reductase(s)
de Groot, R., Chaffin, D. O., Kuehn, M. J., & Smith, A. L. (1991) · Biochemical Journal · doi:10.1042/bj2740657 · Cited by 26
The permeability barrier of Haemophilus influenzae type b against β-lactam antibiotics
Coulton, J. W., Mason, P., & Dorrance, D. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.5.435 · Cited by 25
Peric, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh364 · Cited by 24
Fattorini, L., Vincent, V., Li, B., Xiao, Y., Varnerot, A., Tortoli, E., Piersimoni, C., Mandler, F., Mascellino, M. T., Iona, E., et al. (1996) · Journal of Chemotherapy · doi:10.1179/joc.1996.8.1.37 · Cited by 22
Jacobs, M. R., Bajaksouzian, S., Windau, A., Appelbaum, P. C., Lin, G., Felmingham, D., Dencer, C., Koeth, L. M., Singer, M. E., & Good, C. E. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3269-3276.2002 · Cited by 19
Self-citationXu, J. W., McCabe, B. C., & Koudelka, G. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.9.2866-2873.2001 · Cited by 14
Anti-infective pharmacodynamics – maximizing efficacy, minimizing toxicity
Jacobs, M. R. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.10.010 · Cited by 9
Self-citationIdentification of a ROB-1 beta-lactamase in Haemophilus ducreyi
Maclean, I. W., Slaney, L., Juteau, J., Lévesque, R. C., Albritton, W. L., & Ronald, A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.467 · Cited by 9
Cited by
The Diagnosis and Management of Acute Otitis Media
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3488 · Cited by 1,442
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras-Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 687
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults
Chow, A. W., Benninger, M. S., Brook, I., Brozek, J. L., Goldstein, E. J. C., Hicks, L. A., Pankey, G. A., Seleznick, M., Volturo, G., Wald, E. R., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis370 · Cited by 596
Wald, E. R., Applegate, K. E., Bordley, C., Darrow, D. H., Glode, M. P., Marcy, S. M., Nelson, C. E., Rosenfeld, R. M., Shaikh, N., Smith, M. J., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-1071 · Cited by 526
Metadata
- Authors
- Tristram, S., Jacobs, M. R., & Appelbaum, P. C.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2007-04
- Volume
- 20
- Issue
- 2
- Pages
- 368-389
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2138474149
- Cited by
- 464
- References
- 74
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.